Global Kidney Stones Therapeutic Market 2023-2027

Technavio has been monitoring the kidney stones market and is forecast to grow by USD 566.78 million during 2022-2027, accelerating at a CAGR of 5.42% during the forecast period. Our report on the kidney stones market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing popularity of flexible digital ureteroscopes, rising incidence of urolithiasis among the global population, and increasing prevalence of kidney stone disease.

Technavio's kidney stones market is segmented as below:

By Type

Ureteroscopy
Lithotripsy
Percutaneous nephrolithotomy (PCNL)

By End-user

Hospitals
Specialty clinics
Ambulatory surgical centers

By Geography

North America
Europe
Asia
Rest of World (ROW)

This study identifies the advances in technologies in kidney stones treatment as one of the prime reasons driving the kidney stones market growth during the next few years. Also, rising geriatric population and initiatives to increase public awareness, physician education, and clinical training will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the kidney stones market covers the following areas:

Kidney stones market sizing
Kidney stones market forecast
Kidney stones market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading kidney stones market vendors that include Anvik Biotech, Aristo Pharma GmbH, Bausch Health Co Inc., Biomedix Siomond Pharma, Cipla Ltd., Cmg Biotech Pvt. Ltd., Dr Reddys Laboratories Ltd., Emcure Pharmaceuticals Ltd., GlaxoSmithKline Plc, Intas Pharmaceuticals Ltd., Johnson and Johnson, Macleods Pharmaceuticals Ltd., Medinova Diagnostic Services Ltd., Mission Pharmacal Co., Nostrum Pharmaceuticals LLC, Walter Bushnell, Windlas Biotech Pvt. Ltd., Worth Medicines Pvt. Ltd., Pfizer Inc., and Bayer AG. Also, the kidney stones market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR71823

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2022
3.4 Market outlook: Forecast for 2022-2027
Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global kidney stones market 2017 - 2021
Exhibit 18: Historic Market Size - Data Table on Global kidney stones market 2017 - 2021 ($ million)
4.2 Type Segment Analysis 2017 - 2021
Exhibit 19: Historic Market Size - Type Segment 2017 - 2021 ($ million)
4.3 End-user Segment Analysis 2017 - 2021
Exhibit 20: Historic Market Size - End-user Segment 2017 - 2021 ($ million)
4.4 Geography Segment Analysis 2017 - 2021
Exhibit 21: Historic Market Size - Geography Segment 2017 - 2021 ($ million)
4.5 Country Segment Analysis 2017 - 2021
Exhibit 22: Historic Market Size - Country Segment 2017 - 2021 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2022 and 2027
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2022 and 2027
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2022 and 2027
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2022 and 2027
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
Exhibit 30: Chart on Type - Market share 2022-2027 (%)
Exhibit 31: Data Table on Type - Market share 2022-2027 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Ureteroscopy - Market size and forecast 2022-2027
Exhibit 34: Chart on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
Exhibit 35: Data Table on Ureteroscopy - Market size and forecast 2022-2027 ($ million)
Exhibit 36: Chart on Ureteroscopy - Year-over-year growth 2022-2027 (%)
Exhibit 37: Data Table on Ureteroscopy - Year-over-year growth 2022-2027 (%)
6.4 Lithotripsy - Market size and forecast 2022-2027
Exhibit 38: Chart on Lithotripsy - Market size and forecast 2022-2027 ($ million)
Exhibit 39: Data Table on Lithotripsy - Market size and forecast 2022-2027 ($ million)
Exhibit 40: Chart on Lithotripsy - Year-over-year growth 2022-2027 (%)
Exhibit 41: Data Table on Lithotripsy - Year-over-year growth 2022-2027 (%)
6.5 Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027
Exhibit 42: Chart on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
Exhibit 43: Data Table on Percutaneous nephrolithotomy (PCNL) - Market size and forecast 2022-2027 ($ million)
Exhibit 44: Chart on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
Exhibit 45: Data Table on Percutaneous nephrolithotomy (PCNL) - Year-over-year growth 2022-2027 (%)
6.6 Market opportunity by Type
Exhibit 46: Market opportunity by Type ($ million)
Exhibit 47: Data Table on Market opportunity by Type ($ million)

7 Market Segmentation by End-user

7.1 Market segments
Exhibit 48: Chart on End-user - Market share 2022-2027 (%)
Exhibit 49: Data Table on End-user - Market share 2022-2027 (%)
7.2 Comparison by End-user
Exhibit 50: Chart on Comparison by End-user
Exhibit 51: Data Table on Comparison by End-user
7.3 Hospitals - Market size and forecast 2022-2027
Exhibit 52: Chart on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 53: Data Table on Hospitals - Market size and forecast 2022-2027 ($ million)
Exhibit 54: Chart on Hospitals - Year-over-year growth 2022-2027 (%)
Exhibit 55: Data Table on Hospitals - Year-over-year growth 2022-2027 (%)
7.4 Specialty clinics - Market size and forecast 2022-2027
Exhibit 56: Chart on Specialty clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 57: Data Table on Specialty clinics - Market size and forecast 2022-2027 ($ million)
Exhibit 58: Chart on Specialty clinics - Year-over-year growth 2022-2027 (%)
Exhibit 59: Data Table on Specialty clinics - Year-over-year growth 2022-2027 (%)
7.5 Ambulatory surgical centers - Market size and forecast 2022-2027
Exhibit 60: Chart on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibit 61: Data Table on Ambulatory surgical centers - Market size and forecast 2022-2027 ($ million)
Exhibit 62: Chart on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
Exhibit 63: Data Table on Ambulatory surgical centers - Year-over-year growth 2022-2027 (%)
7.6 Market opportunity by End-user
Exhibit 64: Market opportunity by End-user ($ million)
Exhibit 65: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 67: Chart on Market share by geography 2022-2027 (%)
Exhibit 68: Data Table on Market share by geography 2022-2027 (%)
9.2 Geographic comparison
Exhibit 69: Chart on Geographic comparison
Exhibit 70: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2022-2027
Exhibit 71: Chart on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 72: Data Table on North America - Market size and forecast 2022-2027 ($ million)
Exhibit 73: Chart on North America - Year-over-year growth 2022-2027 (%)
Exhibit 74: Data Table on North America - Year-over-year growth 2022-2027 (%)
9.4 Europe - Market size and forecast 2022-2027
Exhibit 75: Chart on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 76: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
Exhibit 77: Chart on Europe - Year-over-year growth 2022-2027 (%)
Exhibit 78: Data Table on Europe - Year-over-year growth 2022-2027 (%)
9.5 Asia - Market size and forecast 2022-2027
Exhibit 79: Chart on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 80: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
Exhibit 81: Chart on Asia - Year-over-year growth 2022-2027 (%)
Exhibit 82: Data Table on Asia - Year-over-year growth 2022-2027 (%)
9.6 Rest of World (ROW) - Market size and forecast 2022-2027
Exhibit 83: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 84: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
Exhibit 85: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
Exhibit 86: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
9.7 US - Market size and forecast 2022-2027
Exhibit 87: Chart on US - Market size and forecast 2022-2027 ($ million)
Exhibit 88: Data Table on US - Market size and forecast 2022-2027 ($ million)
Exhibit 89: Chart on US - Year-over-year growth 2022-2027 (%)
Exhibit 90: Data Table on US - Year-over-year growth 2022-2027 (%)
9.8 China - Market size and forecast 2022-2027
Exhibit 91: Chart on China - Market size and forecast 2022-2027 ($ million)
Exhibit 92: Data Table on China - Market size and forecast 2022-2027 ($ million)
Exhibit 93: Chart on China - Year-over-year growth 2022-2027 (%)
Exhibit 94: Data Table on China - Year-over-year growth 2022-2027 (%)
9.9 Germany - Market size and forecast 2022-2027
Exhibit 95: Chart on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2022-2027 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2022-2027 (%)
9.10 Canada - Market size and forecast 2022-2027
Exhibit 99: Chart on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 100: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
Exhibit 101: Chart on Canada - Year-over-year growth 2022-2027 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2022-2027 (%)
9.11 UK - Market size and forecast 2022-2027
Exhibit 103: Chart on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 104: Data Table on UK - Market size and forecast 2022-2027 ($ million)
Exhibit 105: Chart on UK - Year-over-year growth 2022-2027 (%)
Exhibit 106: Data Table on UK - Year-over-year growth 2022-2027 (%)
9.12 Market opportunity by geography
Exhibit 107: Market opportunity by geography ($ million)
Exhibit 108: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 109: Impact of drivers and challenges in 2022 and 2027
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 111: Overview on factors of disruption
11.4 Industry risks
Exhibit 112: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 113: Vendors covered
12.2 Market positioning of vendors
Exhibit 114: Matrix on vendor position and classification
12.3 Anvik Biotech
Exhibit 115: Anvik Biotech - Overview
Exhibit 116: Anvik Biotech - Product / Service
Exhibit 117: Anvik Biotech - Key offerings
12.4 Aristo Pharma GmbH
Exhibit 118: Aristo Pharma GmbH - Overview
Exhibit 119: Aristo Pharma GmbH - Product / Service
Exhibit 120: Aristo Pharma GmbH - Key offerings
12.5 Bausch Health Co Inc.
Exhibit 121: Bausch Health Co Inc. - Overview
Exhibit 122: Bausch Health Co Inc. - Business segments
Exhibit 123: Bausch Health Co Inc. - Key news
Exhibit 124: Bausch Health Co Inc. - Key offerings
Exhibit 125: Bausch Health Co Inc. - Segment focus
12.6 Bayer AG
Exhibit 126: Bayer AG - Overview
Exhibit 127: Bayer AG - Business segments
Exhibit 128: Bayer AG - Key news
Exhibit 129: Bayer AG - Key offerings
Exhibit 130: Bayer AG - Segment focus
12.7 Cipla Ltd.
Exhibit 131: Cipla Ltd. - Overview
Exhibit 132: Cipla Ltd. - Business segments
Exhibit 133: Cipla Ltd. - Key news
Exhibit 134: Cipla Ltd. - Key offerings
Exhibit 135: Cipla Ltd. - Segment focus
12.8 Dr Reddys Laboratories Ltd.
Exhibit 136: Dr Reddys Laboratories Ltd. - Overview
Exhibit 137: Dr Reddys Laboratories Ltd. - Business segments
Exhibit 138: Dr Reddys Laboratories Ltd. - Key offerings
Exhibit 139: Dr Reddys Laboratories Ltd. - Segment focus
12.9 Emcure Pharmaceuticals Ltd.
Exhibit 140: Emcure Pharmaceuticals Ltd. - Overview
Exhibit 141: Emcure Pharmaceuticals Ltd. - Product / Service
Exhibit 142: Emcure Pharmaceuticals Ltd. - Key offerings
12.10 GlaxoSmithKline Plc
Exhibit 143: GlaxoSmithKline Plc - Overview
Exhibit 144: GlaxoSmithKline Plc - Business segments
Exhibit 145: GlaxoSmithKline Plc - Key offerings
Exhibit 146: GlaxoSmithKline Plc - Segment focus
12.11 Intas Pharmaceuticals Ltd.
Exhibit 147: Intas Pharmaceuticals Ltd. - Overview
Exhibit 148: Intas Pharmaceuticals Ltd. - Product / Service
Exhibit 149: Intas Pharmaceuticals Ltd. - Key offerings
12.12 Macleods Pharmaceuticals Ltd.
Exhibit 150: Macleods Pharmaceuticals Ltd. - Overview
Exhibit 151: Macleods Pharmaceuticals Ltd. - Product / Service
Exhibit 152: Macleods Pharmaceuticals Ltd. - Key offerings
12.13 Medinova Diagnostic Services Ltd.
Exhibit 153: Medinova Diagnostic Services Ltd. - Overview
Exhibit 154: Medinova Diagnostic Services Ltd. - Product / Service
Exhibit 155: Medinova Diagnostic Services Ltd. - Key offerings
12.14 Pfizer Inc.
Exhibit 156: Pfizer Inc. - Overview
Exhibit 157: Pfizer Inc. - Product / Service
Exhibit 158: Pfizer Inc. - Key news
Exhibit 159: Pfizer Inc. - Key offerings
12.15 Walter Bushnell
Exhibit 160: Walter Bushnell - Overview
Exhibit 161: Walter Bushnell - Product / Service
Exhibit 162: Walter Bushnell - Key offerings
12.16 Windlas Biotech Pvt. Ltd.
Exhibit 163: Windlas Biotech Pvt. Ltd. - Overview
Exhibit 164: Windlas Biotech Pvt. Ltd. - Product / Service
Exhibit 165: Windlas Biotech Pvt. Ltd. - Key offerings
12.17 Worth Medicines Pvt. Ltd.
Exhibit 166: Worth Medicines Pvt. Ltd. - Overview
Exhibit 167: Worth Medicines Pvt. Ltd. - Product / Service
Exhibit 168: Worth Medicines Pvt. Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 169: Inclusions checklist
Exhibit 170: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 171: Currency conversion rates for US$
13.4 Research methodology
Exhibit 172: Research methodology
Exhibit 173: Validation techniques employed for market sizing
Exhibit 174: Information sources
13.5 List of abbreviations
Exhibit 175: List of abbreviations